Role of p16 testing in cervical cancer screening among HIV-infected women

Christine J. McGrath,Rochelle Garcia,Trong T. Trinh,Barbra A. Richardson,Grace John-Stewart,Evans Nyongesa-Malava,Nelly Mugo,Emily Glynn,Samah R. Sakr,Hugo De Vuyst,Michael H. Chung

Role of p16 testing in cervical cancer screening among HIV-infected women

2017

Christine J. McGrath
Rochelle Garcia
Trong T. Trinh
Barbra A. Richardson
Grace John-Stewart
Evans Nyongesa-Malava
Nelly Mugo
Emily Glynn
Samah R. Sakr
Hugo De Vuyst
Michael H. Chung

Background p16 immunohistochemistry is used to evaluate for HPV-associated cervical intraepithelial neoplasia. The diagnostic performance of p16 in HIV infection is unclear.

Keywords:

Cancer research
Cervical cancer
Medicine
Gastroenterology
mass screening
Biopsy
Receiver operating characteristic
Papanicolaou stain
Internal medicine
Papanicolaou Test
Immunosuppression
Histology
Cervical intraepithelial neoplasia

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations